Connection

Alessandro Rambaldi to Enzyme Inhibitors

This is a "connection" page, showing publications Alessandro Rambaldi has written about Enzyme Inhibitors.
Connection Strength

0.084
  1. Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy. Haematologica. 2018 10; 103(10):e469-e472.
    View in: PubMed
    Score: 0.084
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.